Advertisement

Could a Model for the Regulation of ago-Antagonistic Couples Be Related to Various Types of Concrete Systems?

  • E. Bernard-Weil
Part of the NATO Conference Series book series (NATOCS, volume 5)

Abstract

A model for the regulation of ago-antagonistic couples has been built in order to solve some physiopathological and therapeutical problems related to a special type of endocrine disorders, the unbalance which can happen within the dynamics between adrenocortical hormones (ACH) on the one hand, and antidiuretic hormone (ADH) of neuropostpituitary origin on the other hand. These hormones have antagonistic actions as far as water diuresis, water shifts in interstitial and cell body compartments, extracellular osmolarity (natremia), and also glycemia, cell growth and multiplication... are concerned; and agonistic actions as far as volemia, response to the stress... are concerned. One can admit that in the physiological state, there is a balance between both types of secretion: antagonistic balance when x — y (x = ADH action; y = ACH action, with a convenient common unit), agonistic balance when x + y = m (m = parameter). So the reference values of x and y are fixed in a model which returns to 0 the values of u = x — y and v = x + y — m after a perturbation of the system.

Keywords

Circadian Rhythm Parametric Field Physiological Model Concrete System Plasma Vasopressin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. L. Dunn, T. J. Brennan, A. E. Nelson et al., “The role of blood osmolarity and volume in regulating vasopressin secretion in the rat,” J. Clin. Invest., 52, December 1973, pp. 3212–3219.CrossRefGoogle Scholar
  2. 2.
    E. Bernard-Weil, M. Duvelleroy, and Y. Cherruault, “Computer analogic simu tion of a model for the regulation of ago-antagonistic couples,” Int. J. Biomed. Comput., 1977(to appear).Google Scholar
  3. 3.
    E. Bernard-Weil, M. Duvelleroy, and J. Droulez, “Analogical study of a model for the regulation of ago-antagonistic couples. Application to adrenalpostpituitary interrelationships,” Mathem. Biosc., 27, November 1975, pp. 333–348.CrossRefGoogle Scholar
  4. 4.
    L. Share, and R. H. Travis, “Plasma vasopressin concentration in the adrenally insufficient dog,” Endocrinology, 86, February 1970, pp. 196–201.CrossRefGoogle Scholar
  5. 5.
    M. K. Wiley, A. F. Pearlmutter, and R. E. Miller, “Decreased adrenal sensitivity to ACTH in the vasopressin deficient (Brattlboro) rat,” Neuroendocrinology, 14, pp. 257–270, 1974.CrossRefGoogle Scholar
  6. 6.
    C. J. Migeon, F. H. Tyler, and W. P. Mahoney et al., “Dihydroepiandrosterone and androstene levels in human plasma. Effects of age and sex; day-to-day and diurnal variations,” J. Clin. Endocr. Metab., 41, September 1957, pp. 1051–1062.CrossRefGoogle Scholar
  7. 7.
    C. P. George, F. H. Messerli, J. Genest et al., “Diurnal variations of plasma vasopressin in man,” J. Clin. Endocr. Metab., 41, August 1975, pp. 332–338.CrossRefGoogle Scholar
  8. 8.
    R. Wever, “A mathematical model for circadian rhythms,” In: Circadian Clocks, edited by J. Aschoff, North Holland Publishing, Amsterdam, pp. 47–63, 1965.Google Scholar
  9. 9.
    T. Nichols, C. A. Nugent, and F. H. Tyler, “Diurnal variations in suppression of adrenal function by glucocorticoids,” J. Clin. Endocr. Metab., 25, March 1965, pp. 343–349.CrossRefGoogle Scholar
  10. 10.
    E. Bernard-Weil, and C. Da Lage, “Inhibition by Cortisol of the favourable action of lysine-vasopressin on the growth of HeLa cell cultures,” Experimentia, 24, 15 October 1968.CrossRefGoogle Scholar
  11. 11.
    E. Bernard-Weil, J. Landau-Ferey, D. Ancri, and B. Pertuiset, “Clinical effect of combined vasopressin-corticoid therapy on patients with recurrent grade III astrocytomas,” Neuro-chirurgia, 15 July 1972, pp. 127–134.Google Scholar
  12. 12.
    E. Bernard-Weil, and J. P. Pilleron, “Association between vasopressin and corticosteroids in the palliative treatment of advanced breast cancers,” Oncology, 28, pp. 492–508, 1973.CrossRefGoogle Scholar
  13. 13.
    F. E. Yates, R. D. Brennan, and J. Urquhart, “Adrenal glucocorticoid control system,” Fed. Proced., 28, January-February 1969, pp. 71–83.Google Scholar
  14. 14.
    E. Papaikonomou, “A cybernetical approach to the hypothalamo-pituitary/adrenal system,” In: Progress in Brain Research, edited by J. Ariens-Kappers and J. P. Schade, Vol. 38, Elsevier Scientific Publishers Co., Amsterdam, pp. 293–302, 1972Google Scholar
  15. 15.
    D. S. Gann, “Parameters of the stimulus initiating the adrenocortical response to hemorrhage,” Ann. N.Y. Acad. Sci., 156, 21 April 1969, pp. 740–755.CrossRefGoogle Scholar
  16. 16.
    J. C. De Haven, and N. Z. Shapiro, “Simulation of the renal effects of antidiuretic hormone in man,” J. Theor. Biol., 28, August 1970, pp. 261–286.CrossRefGoogle Scholar
  17. 17.
    E. B. Reeve, and L. Kulhanek, In: Physical Bases of Circulatory Transport, Regulation and Exchange, edited by E. B. Reeve, A. C. Guyton, W. B. Saunders, Philadelphia, 1967.Google Scholar
  18. 18.
    E. Bernard-Weil, “L’Arc et la Corde. Un modèle d’antagonismes dialectiques en biologie et sciences humaines,” Maloine, Paris, 1975.Google Scholar
  19. 19.
    E. Bernard-Weil, “Mathematical model of “ago-antagonistic” couples. Consideration of a binary dialectic,” Cybernetica, 18, March 1975, pp. 33–47.Google Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • E. Bernard-Weil
    • 1
  1. 1.Neurosurgical ClinicCHU Pitié-SalpêtrièreParisFrance

Personalised recommendations